BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Nuclear receptor coactivator 3 (NCOA3; SRC3; AIB1)

April 21, 2016 7:00 AM UTC

In vitro testing, cell culture and mouse studies identified a small molecule inhibitor of NCOA3 that could help treat triple-negative breast cancer (TNBC). Screening of a small molecule library, in vi...